The latest closing stock price for 4D Molecular Therapeutics as of September 18, 2024 is 16.82.
An investor who bought $1,000 worth of 4D Molecular Therapeutics stock at the IPO in 2020 would have $-585 today, roughly -1 times their original investment - a -19.72% compound annual growth rate over 4 years.
The all-time high 4D Molecular Therapeutics stock closing price was 52.67 on February 11, 2021.
The 4D Molecular Therapeutics 52-week high stock price is 36.25, which is 115.5% above the current share price.
The 4D Molecular Therapeutics 52-week low stock price is 9.44, which is 43.9% below the current share price.
The average 4D Molecular Therapeutics stock price for the last 52 weeks is 20.14.
An investor who bought $1,000 worth of 4D Molecular Therapeutics stock at the IPO in 2020 would have $-585 today, roughly -1 times their original investment - a -19.72% compound annual growth rate over 4 years.
The all-time high 4D Molecular Therapeutics stock closing price was 52.67 on February 11, 2021.
The 4D Molecular Therapeutics 52-week high stock price is 36.25, which is 115.5% above the current share price.
The 4D Molecular Therapeutics 52-week low stock price is 9.44, which is 43.9% below the current share price.
The average 4D Molecular Therapeutics stock price for the last 52 weeks is 20.14.